Evidence map›Paper›PMID 29300372›Full record

ArticleGenetics in medicine : official journal of the American College of Medical Genetics2018

Adaptation and validation of the ACMG/AMP variant classification framework for MYH7-associated inherited cardiomyopathies: recommendations by ClinGen's Inherited Cardiomyopathy Expert Panel.

Melissa A Kelly, Colleen Caleshu, Ana Morales, Jillian Buchan, Zena Wolf, Steven M Harrison, Stuart Cook, Mitchell W Dillon, John Garcia, Eden Haverfield and 18 more

Open access · hybridAbstract read
In one paragraph

Article in Genetics in medicine : official journal of the American College of Medical Genetics, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 190 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
190citing papers in PubMed, 1 pooled it
32.9field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

190 citing papers in PubMed, 1 synthesis or guideline pooled it, 363 citations in OpenAlex.

  1. Pooled it
  2. Trial
  3. Article
  4. Article
  5. Programmed ventricular stimulation for risk stratification in symptomatic athletes with nonischemic left ventricular scar and preserved ejection fraction.Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology · 2026
    Article
  6. ACMG/AMP variant classification specifications from the ClinGen Epilepsy Sodium Channel Variant Curation Expert Panel.Genetics in medicine : official journal of the American College of Medical Genetics · 2026
    Article
  7. AAVC: An automated framework for high-accuracy ACMG-based variant classification.Genetics in medicine : official journal of the American College of Medical Genetics · 2026
    Article
  8. Article
  9. Review
  10. Article
  11. Review
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Human mutation · 2026
    Article
  20. Article

130 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

28 authors at 17 institutions in 4 countries.

Melissa A KellyLaboratory for Molecular Medicine, Partners Healthcare Personalized Medicine, Boston, Massachusetts, USA.
Colleen CaleshuStanford Center for Inherited Cardiovascular Disease, Stanford University, Stanford, California, USA.
Ana MoralesDivision of Human Genetics, Department of Internal Medicine, Ohio State University, Columbus, Ohio, USA.
Jillian BuchanLaboratory for Molecular Medicine, Partners Healthcare Personalized Medicine, Boston, Massachusetts, USA.
Zena WolfLaboratory for Molecular Medicine, Partners Healthcare Personalized Medicine, Boston, Massachusetts, USA.
Steven M HarrisonLaboratory for Molecular Medicine, Partners Healthcare Personalized Medicine, Boston, Massachusetts, USA.
Stuart CookNational Heart and Lung Institute, Imperial College London, London, UK.
Mitchell W DillonLaboratory for Molecular Medicine, Partners Healthcare Personalized Medicine, Boston, Massachusetts, USA.
John GarciaInvitae Inc., San Francisco, California, USA.
Eden HaverfieldInvitae Inc., San Francisco, California, USA.
Jan D H JongbloedDepartment of Genetics, University of Groningen, University Medical Center Groningen, Groningen, Netherlands.
Daniela MacayaGeneDx Laboratories, Gaithersburg, Maryland, USA.
Arjun ManraiHarvard School of Public Health, Boston, Massachusetts, USA.
Kate OrlandClinical Science Center, University of Wisconsin, Madison, Wisconsin, USA.
Gabriele RichardGeneDx Laboratories, Gaithersburg, Maryland, USA.
Katherine SpoonamoreKrannert Institute of Cardiology, Indiana University, Indianapolis, Indiana, USA.
Matthew ThomasDivision of Genetics, Department of Pediatrics, University of Virginia, Charlottesville, Virginia, USA.
Kate ThomsonOxford Medical Genetics Laboratory, Oxford University Hospitals NHS Foundation Trust, The Churchill Hospital, Oxford, UK.
Lisa M VincentGeneDx Laboratories, Gaithersburg, Maryland, USA.
Roddy WalshNational Heart and Lung Institute, Imperial College London, London, UK.
Hugh WatkinsRadcliffe Department of Medicine, University of Oxford, Oxford, UK.
Nicola WhiffinNational Heart and Lung Institute, Imperial College London, London, UK.
Jodie InglesAgnes Ginges Centre for Molecular Cardiology, Centenary Institute and University of Sydney, Sydney, Australia.
J Peter van TintelenDepartment of Clinical Genetics, Academic Medical Center, University of Amsterdam, Amsterdam, Netherlands.
Christopher SemsarianAgnes Ginges Centre for Molecular Cardiology, Centenary Institute and University of Sydney, Sydney, Australia.
James S WareNational Heart and Lung Institute, Imperial College London, London, UK.
Ray HershbergerDivision of Human Genetics, Department of Internal Medicine, Ohio State University, Columbus, Ohio, USA.
Birgit FunkeLaboratory for Molecular Medicine, Partners Healthcare Personalized Medicine, Boston, Massachusetts, USA.
Mass General Brigham · USGenex Systems (United States) · USImperial College London · GBCentenary Institute · AUInvitae (United States) · USThe Ohio State University · USAcademic Medical Center · NLChurchill Hospital · GBHarefield Hospital · GBHarvard University · USIndiana University – Purdue University Indianapolis · USMassachusetts General Hospital · USStanford University · USUniversity of Groningen · NLUniversity of Oxford · GBUniversity of Virginia · USUniversity of Wisconsin–Madison · US

Funding

Resource ProjectU41HG006834 · NHGRI · BRIGHAM AND WOMEN'S HOSPITAL · PI REHM, HEIDI L · 2013 to 2020
$26.9M
The Future of PharmGKB Funding Under NHGRIU41HG009649 · NHGRI · STANFORD UNIVERSITY · PI BUSTAMANTE, CARLOS DANIEL · 2017 to 2020
$13.4M
The Clinical Genome Resource - Expert Curation and EHR IntegrationU41HG009650 · NHGRI · UNIV OF NORTH CAROLINA CHAPEL HILL · PI BERG, JONATHAN S, GODDARD, KATRINA A. · 2017 to 2020
$13.3M
A Knowledge Base for Clinically Relevant Genes and VariantsU01HG007437 · NHGRI · UNIV OF NORTH CAROLINA CHAPEL HILL · PI BERG, JONATHAN S, EVANS, JAMES PHILIP · 2013 to 2016
$9.0M
British Heart Foundation RG/12/16/29939British Heart Foundation SP/10/10/28431Department of Health NIHR-HCS-D13-04-006Medical Research Council MC_U120085815Medical Research Council MC_UP_1102/20NHGRI NIH HHS U01 HG007437NHGRI NIH HHS U41 HG006834NHGRI NIH HHS U41 HG009649NHGRI NIH HHS U41 HG009650Wellcome TrustWellcome Trust 107469/Z/15/Z
6 · The paper itself

Abstract

PurposeIntegrating genomic sequencing in clinical care requires standardization of variant interpretation practices. The Clinical Genome Resource has established expert panels to adapt the American College of Medical Genetics and Genomics/Association for Molecular Pathology classification framework for specific genes and diseases. The Cardiomyopathy Expert Panel selected MYH7, a key contributor to inherited cardiomyopathies, as a pilot gene to develop a broadly applicable approach.MethodsExpert revisions were tested with 60 variants using a structured double review by pairs of clinical and diagnostic laboratory experts. Final consensus rules were established via iterative discussions.ResultsAdjustments represented disease-/gene-informed specifications (12) or strength adjustments of existing rules (5). Nine rules were deemed not applicable. Key specifications included quantitative frameworks for minor allele frequency thresholds, the use of segregation data, and a semiquantitative approach to counting multiple independent variant occurrences where fully controlled case-control studies are lacking. Initial inter-expert classification concordance was 93%. Internal data from participating diagnostic laboratories changed the classification of 20% of the variants (n = 12), highlighting the critical importance of data sharing.ConclusionThese adapted rules provide increased specificity for use in MYH7-associated disorders in combination with expert review and clinical judgment and serve as a stepping stone for genes and disorders with similar genetic and clinical characteristics.

Indexed as

Genetic VariationAllelesCardiac MyosinsCardiomyopathiesClinical Decision-MakingGene FrequencyGenetic Diseases, InbornGenetic TestingHumansMyosin Heavy ChainsPhenotypeReproducibility of ResultsCardiac MyosinsMYH7 protein, humanMyosin Heavy Chains

Identifiers

PMID29300372
PMCPMC5876064
OpenAlexW2782210658

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.